Kristian Helin
Professor Kristian Helin is the chief executive of the Institute of Cancer Research in London and a leading figure in cancer research. He has recently been in the news for discussing the promising results of a clinical trial that showed immunotherapy, specifically pembrolizumab, can double the time patients with head and neck cancer remain free from evidence of the disease. His insights highlight the transformative potential of immunotherapy in cancer treatment.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Vietnam:
Kristian Helin, the CEO of ICR, affirmed that the injection represents a significant advancement in modern medicine.
9
Hungary:
Professor Kristian Helin is the CEO of the Institute of Cancer Research and commented on the significant advancements in treatment.
9
Romania:
Professor Kristian Helin is the executive director of the Institute of Cancer Research.
9
Ireland:
Prof Kristian Helin, chief executive of the ICR, emphasized the significance of the study in developing new cancer treatments.
9
United Kingdom:
Prof Kristian Helin, the chief executive of the ICR, emphasized the significance of the study in developing new cancer treatments.
9
United Kingdom:
Prof Kristian Helin, the chief executive of the Institute of Cancer Research, said: 'Immunotherapy continues to deliver ...'
8